Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: A genotype-phenotype study
•Breast cancer (BC) is the most common cancer among women.•BC is considered the most lethal disease among women in the developing countries.•This study amid to investigate the association of SMYD3 gene polymorphisms with BC.•The overexpression of the SMYD3 gene could lead BC.•Significant genetic ass...
Gespeichert in:
Veröffentlicht in: | Gene 2020-02, Vol.728, p.144281-144281, Article 144281 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Breast cancer (BC) is the most common cancer among women.•BC is considered the most lethal disease among women in the developing countries.•This study amid to investigate the association of SMYD3 gene polymorphisms with BC.•The overexpression of the SMYD3 gene could lead BC.•Significant genetic association was found between SMYD3 gene promoter variants and BC.
Genetic predisposition to breast cancer (BC) has become one of the most studied aspects of the disease. Advances in the field of cancer research have revealed the role of different genetic polymorphisms within genes of interest in the development of BC. This study aimed to explore the impact of a variable number tandem repeat (VNTR) genetic variant found within the SET and MYND domain containing protein 3 (SMYD3) gene on BC risk in Jordan and examine key clinical and pathological prognostic factors. Genotyping of blood samples from 180 cases with breast cancer and 180 healthy individuals from the Jordanian population was carried out via a combination of PCR and agarose gel electrophoresis. A highly significant association was found at level of genotype (P-value = 0.009) and allele (P-value = 0.0001) between BC development and the VNTR variant in the SMYD3 gene among Jordanian women. Moreover, we found that the VNTR of SMYD3 gene may interfere with BC risk among patients with different immunohistochemistry (IHC) profiles (P-value |
---|---|
ISSN: | 0378-1119 1879-0038 |
DOI: | 10.1016/j.gene.2019.144281 |